Skip to main content
. 2021 Oct 22;13:753242. doi: 10.3389/fnagi.2021.753242

TABLE 3.

pNfL and cNfL levels according to the accuracy level of the categories of the Revised El Escorial diagnostic criteria and to genetic status (i.e., wild type vs. ALS gene mutations).

Revised El Escorial criteria N pNfL Median (IQR) N cNfL Median (IQR)
Possible ALS 38 64.9 (27.6–101.3) 25 4536 (2232–8853)
Probable laboratory-supported ALS 31 45.8 (31.4–70.7) 24 5100 (3145.2–7760)
Probable ALS 68 86.1 (57.7–127.2) 45 7572 (4770–15569)
Definite ALS 31 100.5 (58.8–135.5) 19 10892.4 (6156–14629)
Genetic status N pNfL Median (IQR) N cNfL Median (IQR)
Wild-type 137 73.5 (43.9–113.7) 98 6317 (3574–13476)
SOD1 6 36.0 (14.0–59.4) 2 2252; 4536
TARDBP 2 32.8; 51.8 1 3018.5
FUS 1 37.2 0 NA
C9Orf72 18 107.1 (64.5–125.3) 11 10796 (7950–12031)

Biomarker values are expressed in pg/ml. Key: ALS, amyotrophic lateral sclerosis; cNfL, cerebrospinal neurofilament light chain; IQR, interquartile range; N, number; NA, not available; pNfL, plasma neurofilament light chain.